Ruxolitinib is a medication used for the treatment of intermediate or high-risk myelofibrosis, a type of myeloproliferative neoplasm that affects the bone marrow; polycythemia vera, when there has been an inadequate response to or intolerance of hydroxyurea; and steroid-refractory acute graft-versus-host disease.
Member Since 1 Year
Nature of Business Manufacturer
GST No. 07AATCS2058N1ZM
For Buyer 
For Seller 
Help 
Paschim Vihar, Delhi 